Top Markets
Coin of the day
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Ранг среди акций #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Цена акции
$0.00953895
Последняя синхронизация: 2024-05-22
Рыночная капитализация
$1.28M
Изменение (1 день)
0.06%
Изменение (1 год)
0.00%
Страна
GB
Торговля Evgen Pharma plc (EVG)

Категория

Коэффициент P/S для Evgen Pharma plc (EVG)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Evgen Pharma plc, текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Evgen Pharma plc с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE